Variables | Patients (N) | Univariate analysis | Multivariate analysis | ||
---|---|---|---|---|---|
HR (95% CI) | P | HR (95% CI) | P | ||
Age | |||||
< 60/≥ 60 | 572/506 | 1.67 (1.13–2.48) | 0.010 | 2.46 (1.37–4.42) | 0.003 |
Pathologic stage | |||||
I–II/III–IV | 799/279 | 2.47 (1.67-–3.66) | 0.000 | 2.86 (1.15–7.11) | 0.024 |
Stage T | |||||
T1–T2/T3–T4 | 901/177 | 1.26 (0.8–1.97) | 0.323 | 1.41 (0.59–3.35) | 0.440 |
Stage N | |||||
N0/NX | 512/566 | 2.56 (1.65–3.95) | 0.000 | 1.12 (0.53–2.37) | 0.773 |
Stage M | |||||
M0/MX | 901/177 | 1.79 (1.05–3.07) | 0.034 | 0.48 (0.17–1.33) | 0.156 |
ER | |||||
Negative/positive | 232/796 | 0.58 (0.38–0.88) | 0.011 | 1.15 (0.31–4.32) | 0.837 |
PR | |||||
Negative/positive | 338/687 | 0.57 (0.38–0.86) | 0.007 | 0.54 (0.2–1.47) | 0.226 |
Her2 | |||||
Negative/positive | 552/163 | 2.3 (1.29–4.1) | 0.005 | 2.24 (1.06–4.72) | 0.034 |
Triple negative | |||||
No/yes | 598/112 | 1.59 (0.82–3.07) | 0.168 | 1.69 (0.46–6.19) | 0.428 |
Risk score | |||||
Low/high | 593/593 | 2.16 (1.42–3.29) | 0.000 | 2.26 (1.15–4.43) | 0.017 |